Tejnaksh Health.

{
  "main_header": {
    "sid": 999962,
    "name": "Tejnaksh Health.",
    "stock_name": "Tejnaksh Health.",
    "full_name": "Tejnaksh Healthcare Ltd",
    "name_url": "stocks-analysis/tejnaksh-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.69",
    "chg": -0.62,
    "chgp": "-4.05%",
    "dir": -1,
    "prev_price": "15.31",
    "mcapval": "29.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539428,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE030T01027",
    "curr_date": "Jun 29, 02:23 PM",
    "curr_time": "14:27 PM",
    "last_traded_at": "Jun 29, 02:23 PM IST",
    "bse_nse_vol": "13.51 k",
    "exc_status": "Active",
    "traded_date": "Jun 29, 2026",
    "traded_date_str": "2026 06 29",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tejnaksh-health-999962-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tejnaksh Healthcare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-is-rated-strong-sell-4072921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_mojoScore_4072921.png",
        "date": "2026-06-25 10:11:35",
        "description": "Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 June 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Falls 4.37%: Valuation Shifts and Mixed Financial Signals Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-falls-437-valuation-shifts-and-mixed-financial-signals-shape-the-week-4052056",
        "imagepath": "",
        "date": "2026-06-13 16:20:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Q4 FY26 results released; margins recover amid revenue pressures</p>\n                    <p><strong>1 June:</strong> Valuation shifts signal changing price attractiveness</p>\n                    <p><strong>2 June:</strong> Mojo Grade upgraded from Strong Sell to Sell on improved valuation metrics</p>\n                    <p><strong>5 June:</strong> Stock closes week at Rs.14.67, down 4.37%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.15.34</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><d..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Downgraded to Strong Sell Amid Technical and Financial Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-downgraded-to-strong-sell-amid-technical-and-financial-weakness-4040524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_mojoScore_4040524.png",
        "date": "2026-06-09 08:52:49",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 8 June 2026, reflecting a deterioration in its technical outlook despite an improved valuation grade. The micro-cap healthcare services company’s shares have declined sharply, with a day drop of 6.07% and a one-year return of -38.01%, significantly underperforming the Sensex benchmark. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered this rating change."
      },
      {
        "title": "Are Tejnaksh Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-tejnaksh-healthcare-ltd-latest-results-good-or-bad-4032420",
        "imagepath": "",
        "date": "2026-06-02 19:32:07",
        "description": "Tejnaksh Healthcare Ltd's latest financial results for the quarter ending March 2026 illustrate a company facing significant operational challenges. The net sales for this quarter contracted by 20.56% year-on-year to ₹2.55 crores, marking the third consecutive quarter of year-on-year revenue decline. This trend raises concerns about the company's ability to attract and retain patients, particularly in a competitive healthcare market.\n\nDespite the decline in sales, the company reported a consolidated net profit of ₹0.36 crores, which reflects a sequential recovery of 20.00% from the previous quarter, although it represents a year-on-year decrease of 29.41%. This recovery in profitability is attributed to improved operating margins, which increased to 27.84% from 21.81% in the same quarter last year, indicating effective cost management and operational efficiency.\n\nThe operating profit margin improvement sugg..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Upgraded to Sell on Improved Valuation Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-upgraded-to-sell-on-improved-valuation-metrics-4030278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_mojoScore_4030278.png",
        "date": "2026-06-02 09:07:29",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, driven primarily by a significant improvement in valuation metrics. Despite flat financial performance in the latest quarter and ongoing challenges in profitability, the stock’s more attractive valuation profile has prompted a reassessment of its investment appeal within the healthcare services sector."
      },
      {
        "title": "Tejnaksh Healthcare Q4 FY26: Margins Recover Amid Revenue Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/tejnaksh-healthcare-q4-fy26-margins-recover-amid-revenue-pressures-4028820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_quaterlyResult_4028820.png",
        "date": "2026-06-01 17:18:49",
        "description": "Tejnaksh Healthcare Ltd., the Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.36 crores for Q4 FY26 (January-March 2026), marking a sequential recovery of 20.00% over Q3 FY26 but declining 29.41% year-on-year. With a market capitalisation of ₹31.00 crores, the micro-cap healthcare services provider faces persistent revenue headwinds even as operating margins show signs of stabilisation."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-valuation-shifts-signal-changing-price-attractiveness-4025457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_valuationdot_4025457.png",
        "date": "2026-06-01 08:06:08",
        "description": "Tejnaksh Healthcare Ltd, a micro-cap player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite this improvement in price metrics, the company’s stock performance remains mixed, with significant underperformance over longer time horizons compared to the Sensex. This article analyses the recent valuation changes, peer comparisons, and the implications for investors."
      },
      {
        "title": "Tejnaksh Healthcare Gains 6.38%: Valuation Shift Amidst Strong Sell Rating",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-gains-638-valuation-shift-amidst-strong-sell-rating-4022896",
        "imagepath": "",
        "date": "2026-05-30 13:05:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock surged 4.99% on strong intraday gains</p>\n                    <p><strong>26 May:</strong> Downgrade to Strong Sell announced alongside valuation shift</p>\n                    <p><strong>27 May:</strong> Continued price recovery with 1.79% gain</p>\n                    <p><strong>29 May:</strong> Slight pullback of 0.32% to close the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.14.42</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.15.34</div><div class=..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Downgraded to Strong Sell Amidst Mixed Valuation and Weak Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-downgraded-to-strong-sell-amidst-mixed-valuation-and-weak-financial-trends-4012996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TejnakshHealthc_mojoScore_4012996.png",
        "date": "2026-05-26 08:48:49",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 25 May 2026, driven primarily by a reassessment of its valuation metrics. Despite this upgrade, the company continues to face significant challenges in financial performance and market returns, underscoring a complex investment outlook for this micro-cap healthcare services provider."
      }
    ],
    "total": 181,
    "sid": "999962",
    "stock_news_url": "https://www.marketsmojo.com/news/tejnaksh-healthcare-999962"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Jun-2026",
      "details": "Please refer attached closure of trading window.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.",
      "datetime": "30-May-2026",
      "details": "1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31 2026 and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations 2015 regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1 2026 and ending on March 31 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue in view of the postponement of the Companys expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.",
      "datetime": "30-May-2026",
      "details": "Please find enclosed Audited financial results for March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>5:10</strong> stock split, ex-date: 19 Jul 23",
          "dt": "2023-07-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>36:10</strong> bonus issue, ex-date: 26 Apr 18",
          "dt": "2018-04-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Tejnaksh Healthcare Ltd is Rated Strong Sell

2026-06-25 10:11:35

Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 June 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Tejnaksh Healthcare Ltd Falls 4.37%: Valuation Shifts and Mixed Financial Signals Shape the Week

2026-06-13 16:20:32

Key Events This Week

1 June: Q4 FY26 results released; margins recover amid revenue pressures

1 June: Valuation shifts signal changing price attractiveness

2 June: Mojo Grade upgraded from Strong Sell to Sell on improved valuation metrics

5 June: Stock closes week at Rs.14.67, down 4.37%

Week Open

Rs.15.34

Week Close

Read full news article

Tejnaksh Healthcare Ltd Downgraded to Strong Sell Amid Technical and Financial Weakness

2026-06-09 08:52:49

Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 8 June 2026, reflecting a deterioration in its technical outlook despite an improved valuation grade. The micro-cap healthcare services company’s shares have declined sharply, with a day drop of 6.07% and a one-year return of -38.01%, significantly underperforming the Sensex benchmark. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered this rating change.

Read full news article

Are Tejnaksh Healthcare Ltd latest results good or bad?

2026-06-02 19:32:07

Tejnaksh Healthcare Ltd's latest financial results for the quarter ending March 2026 illustrate a company facing significant operational challenges. The net sales for this quarter contracted by 20.56% year-on-year to ₹2.55 crores, marking the third consecutive quarter of year-on-year revenue decline. This trend raises concerns about the company's ability to attract and retain patients, particularly in a competitive healthcare market. Despite the decline in sales, the company reported a consolidated net profit of ₹0.36 crores, which reflects a sequential recovery of 20.00% from the previous quarter, although it represents a year-on-year decrease of 29.41%. This recovery in profitability is attributed to improved operating margins, which increased to 27.84% from 21.81% in the same quarter last year, indicating effective cost management and operational efficiency. The operating profit margin improvement sugg...

Read full news article

Tejnaksh Healthcare Ltd Upgraded to Sell on Improved Valuation Metrics

2026-06-02 09:07:29

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, driven primarily by a significant improvement in valuation metrics. Despite flat financial performance in the latest quarter and ongoing challenges in profitability, the stock’s more attractive valuation profile has prompted a reassessment of its investment appeal within the healthcare services sector.

Read full news article

Tejnaksh Healthcare Q4 FY26: Margins Recover Amid Revenue Pressures

2026-06-01 17:18:49

Tejnaksh Healthcare Ltd., the Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.36 crores for Q4 FY26 (January-March 2026), marking a sequential recovery of 20.00% over Q3 FY26 but declining 29.41% year-on-year. With a market capitalisation of ₹31.00 crores, the micro-cap healthcare services provider faces persistent revenue headwinds even as operating margins show signs of stabilisation.

Read full news article

Tejnaksh Healthcare Ltd Valuation Shifts Signal Changing Price Attractiveness

2026-06-01 08:06:08

Tejnaksh Healthcare Ltd, a micro-cap player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite this improvement in price metrics, the company’s stock performance remains mixed, with significant underperformance over longer time horizons compared to the Sensex. This article analyses the recent valuation changes, peer comparisons, and the implications for investors.

Read full news article

Tejnaksh Healthcare Gains 6.38%: Valuation Shift Amidst Strong Sell Rating

2026-05-30 13:05:55

Key Events This Week

25 May: Stock surged 4.99% on strong intraday gains

26 May: Downgrade to Strong Sell announced alongside valuation shift

27 May: Continued price recovery with 1.79% gain

29 May: Slight pullback of 0.32% to close the week

Week Open

Rs.14.42

Week Close

Rs.15.34

Read full news article

Tejnaksh Healthcare Ltd Downgraded to Strong Sell Amidst Mixed Valuation and Weak Financial Trends

2026-05-26 08:48:49

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 25 May 2026, driven primarily by a reassessment of its valuation metrics. Despite this upgrade, the company continues to face significant challenges in financial performance and market returns, underscoring a complex investment outlook for this micro-cap healthcare services provider.

Read full news article

View All News